Michael Kelliher
Direttore/Membro del Consiglio presso CAPRICOR THERAPEUTICS, INC.
Patrimonio netto: 1 M $ in data 31/05/2024
Profilo
Michael Kelliher is currently an Independent Director at Capricor Therapeutics, Inc. since 2023 and an Executive VP-Corporate Development & Strategy at Ardelyx, Inc. since 2024.
Previously, he worked as a Group Vice President-Merger & Acquisition at Horizon Therapeutics Plc.
He completed his undergraduate degree at University College Cork.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
ARDELYX, INC.
0.07% | 25/03/2024 | 160 000 ( 0.07% ) | 1 M $ | 31/05/2024 |
| 18/03/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Posizioni attive di Michael Kelliher
| Società | Posizione | Inizio |
|---|---|---|
| CAPRICOR THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/09/2023 |
| ARDELYX, INC. | Corporate Officer/Principal | 25/03/2024 |
Precedenti posizioni note di Michael Kelliher
| Società | Posizione | Fine |
|---|---|---|
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Corporate Officer/Principal | - |
Formazione di Michael Kelliher
| University College Cork | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| CAPRICOR THERAPEUTICS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Horizon Therapeutics Plc
 Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Michael Kelliher
